A family office introduction to life-insurance-linked assets

Most family office CIOs encounter life-insurance-linked investing the same way: a peer mentions it in passing, a manager pitches it at a conference, or an internal analyst surfaces it after screening for genuinely uncorrelated assets. The category is small, technically dense, and unfamiliar enough that the first instinct is often to set it aside. The goal of this article is to make that initial encounter more useful by describing what the asset category actually is, how it is regulated, where its returns come from, and the conditions under which it tends to fit a family office portfolio.

Nothing in this introduction is intended as a sales pitch. The intent is to provide the kind of overview an allocator might want before deciding whether the category is worth an initial meeting.

What is life-insurance-linked investing

Life-insurance-linked investing is the practice of holding, lending against, or otherwise taking economic exposure to in-force life insurance and annuity contracts. The category sits within the broader universe of insurance-linked strategies, which also includes catastrophe bonds and reinsurance sidecars. What distinguishes life-insurance-linked assets from those property-and-casualty cousins is the underlying risk: mortality and longevity, rather than hurricane, earthquake, or wildfire.

Within life-insurance-linked investing, life settlements are the most commonly held asset and the focus of most institutional life-settlement funds. Sea Point has extended the strategy to incorporate two complementary asset types — collateralized policy-backed loans and payout annuities — that most life-settlement funds do not hold. Each of the three rests on a different segment of the insurance contract universe and produces a distinct return profile. The combination, in our view, produces a more resilient portfolio than any single asset type can deliver alone.

Life settlements

A life settlement is the purchase of an in-force permanent life insurance policy from its original policyholder for an upfront payment that exceeds the policy's cash surrender value. After the sale, the buyer becomes owner and beneficiary, pays the ongoing premiums required to keep the policy in force, and ultimately collects the death benefit. The asset is mortality-linked: the timing and magnitude of the return depend on when the insured passes away, not on capital markets. A fuller treatment is available at seapoint.capital/strategy/life-settlements.

Collateralized policy-backed loans

Collateralized loans in this market are term loans extended to institutional borrowers and secured by life insurance policies the borrowers own. The lender's return comes from contractual interest rather than from mortality timing; the policy collateral protects principal. Compared to life settlements, these loans are shorter-duration, more predictable in timing, and steadier in monthly accretion. A deeper treatment is available at seapoint.capital/strategy/collateralized-loans.

Payout annuities

A payout annuity is a contract issued by a regulated life insurance carrier that pays a fixed stream of monthly income for the life of an annuitant or for a defined period. Held as an investable asset, payout annuities deliver predictable monthly cash flow whose total return depends on how long the annuitant lives. They carry the opposite mortality exposure of life settlements, which is why portfolios that combine the two see a partial offset of longevity risk at the aggregate level. A deeper treatment is available at seapoint.capital/strategy/payout-annuities.

Together, these three contract types form a small but coherent universe. Each is regulated, each is governed by enforceable contracts, and each produces cash flows whose timing depends on events outside the financial markets. Holding all three in a single portfolio — rather than only life settlements, as is more typical in the industry — is one of the defining elements of how Sea Point constructs the strategy.

Where the returns come from

It is worth being explicit about the economic source of returns in life-insurance-linked investing, because the framing is sometimes muddled in marketing material. Returns in this asset category do not come from outsmarting insurance carriers, from exploiting pricing inefficiencies, or from arbitraging actuarial errors. They come from three structural sources.

First, risk transfer. Life insurance policyholders and borrowing counterparties have specific liabilities and specific liquidity needs. Institutional capital provides the other side of those transactions and is compensated for accepting risk that the original counterparty wished to shed. This is the same economic logic that pays reinsurers, underwriters, and lenders generally.

Second, pooling at scale. Mortality timing is uncertain for any single individual but highly predictable in aggregate across a sufficiently large and diversified population. An institutional buyer holding many policies converts individually idiosyncratic risk into something close to a probability distribution. The diversification benefit is itself a source of value: the pooled portfolio is worth more than the sum of the individual policies because the variance around the central expectation falls.

Third, time value of capital. Long-duration cash flows committed to long-duration assets command a premium relative to short-duration capital. Life-insurance-linked assets, particularly life settlements and longevity-linked annuities, require holding periods measured in years. The investor is compensated for the patience and for the foregone liquidity.

The regulatory framework

Life insurance is regulated at the state level in the United States. The result is a fifty-state patchwork that is more uniform than it sounds, because most states have adopted statutes built on one of two model acts.

The NAIC Viatical Settlements Model Act, originally adopted in 1993 and revised several times since (most consequentially in 2007 to address stranger-originated life insurance), sets the framework many states have adopted. The NCOIL Life Settlements Model Act offers an alternative template. Together with state-specific modifications, these statutes govern licensing, disclosure, consent, privacy, and conduct in the secondary market for life insurance.

Three doctrines deserve particular attention from an allocator's perspective.

Insurable interest

Insurable interest is the legal principle that requires the original purchaser of a life insurance policy to have a legitimate financial or familial reason to insure the life in question. It is the doctrine that distinguishes legitimate life insurance from wagering on lives. Life settlements involve policies that were originally issued with proper insurable interest and have since become unwanted by the policyholder; the secondary market is not a market for newly originated policies created for speculative purposes. The 2007 NAIC and NCOIL revisions reinforced this distinction by imposing waiting periods and prohibitions on stranger-originated life insurance.

State licensing of providers and brokers

Institutional buyers (life settlement providers) and intermediaries representing policyholders (life settlement brokers) must be licensed in each state where they transact. Licensing entails financial responsibility, background checks, periodic examinations, and continuing education in many jurisdictions. Brokers owe a fiduciary duty to the policyholder they represent and are required to shop the policy among multiple licensed buyers.

Disclosure and consent

Selling policyholders receive statutorily mandated disclosures covering alternatives to settlement (retention, surrender, accelerated death benefits), the right to rescind within a defined window after closing, the identity of the buyer, the gross offer, and all fees and commissions deducted from the proceeds. Explicit written consent is required, and privacy protections govern the handling of the insured's medical and personal information.

The collective effect of state regulation, model-act standardization, licensing, and disclosure is that life settlements are among the more thoroughly regulated alternative asset classes available to institutional investors. Payout annuities and carrier-issued products carry their own framework of state-level solvency regulation, reserve requirements, and guaranty association backstops.

A brief history and the current market

The viatical settlement market emerged in the late 1980s, initially serving patients with serious illnesses (often AIDS) who wished to monetize life insurance policies. The broader life settlement market developed in the 1990s and 2000s as actuarial methodology, regulatory clarity, and institutional capital all matured. The 2007 NAIC revisions and parallel NCOIL framework, together with state adoption of related statutes, addressed early-stage concerns about stranger-originated life insurance and consumer protection.

The Life Insurance Settlement Association (LISA), the industry trade group founded in 1994, publishes annual market data tracking secondary-market volume. LISA reports indicate that policyholders received approximately $842 million in proceeds from life settlement transactions in 2023, representing roughly $707 million in additional value compared with the surrender or lapse alternatives those policies would otherwise have faced. Independent industry research suggests substantially larger potential market depth: Conning, an insurance-focused asset management firm, has estimated annual gross market potential at multiple billions of dollars, with addressable opportunity considerably larger as the U.S. population ages and large cohorts of policyholders reach the ages at which settlements become economically relevant.

Where life-insurance-linked assets fit in a portfolio

For most family offices, the natural home for life-insurance-linked assets is within the alternative or uncorrelated bucket. Allocators frequently group the category with reinsurance, catastrophe bonds, and other insurance-linked strategies in a sub-sleeve focused on insurance risk premia.

The case for inclusion rests on three structural properties. First, the underlying risk factor — mortality timing on the policy side, longevity on the annuity side — is essentially unrelated to the macroeconomic and financial variables that drive most of a typical portfolio. A recession does not change when a given insured will pass away; an interest rate shock does not directly alter mortality outcomes. Second, the principal cash flows are contractual obligations of regulated insurance carriers, whose creditworthiness is monitored by state insurance departments and rated by independent rating agencies. Third, returns are realized through actual cash distributions over time, rather than relying on mark-to-market revaluation, which provides a different and arguably more robust source of return than mark-to-market alternatives.

How much exposure makes sense depends entirely on the rest of the portfolio. Family offices with concentrated public equity exposure may find the diversification benefit larger; those with substantial private equity, real assets, or operating business exposure may find the benefit smaller but still meaningful. The category is rarely a large allocation in absolute terms. It tends to function as a diversifying complement rather than a core holding.

Suitability and the honest caveats

Three features of life-insurance-linked investing make it unsuitable for some investors. None of them are surprising once stated.

• •Holding periods are long. Life settlements in particular require capital commitments measured in years. Policy-backed loans are shorter but still less liquid than public credit. Investors who may need access to capital on short notice should weight this category accordingly.
• •Illiquidity is real. Secondary markets exist for institutional life settlement portfolios but are thin compared with public markets. Position sizing should reflect the practical inability to sell quickly at modeled values.
• •Tax treatment is partnership-flavored. Most institutional vehicles in this category issue a Schedule K-1 to investors rather than a Form 1099. K-1 reporting is more complex than 1099 reporting. Many family offices and their tax advisors are accustomed to K-1s; those who are not should review the implications with counsel.
• •Complexity is non-trivial. Understanding the asset class properly requires comfort with actuarial concepts, insurance regulation, and the mechanics of long-duration cash flow modeling. Investors who prefer simplicity will find this category demanding.

One further caveat deserves separate mention. Some investors will conclude on ethical or aesthetic grounds that they prefer not to hold mortality-linked assets. That decision is legitimate and should be respected; the asset class is not a moral test. A fuller examination of the ethical question, including the case in favor of and the case against, is the subject of a companion article on the ESG dimensions of life settlements at The ESG case for life settlements.

Why family offices specifically are well-positioned

Family offices have three structural advantages over many other institutional buyers when it comes to evaluating insurance-linked strategies.

The first is time horizon. Most family offices manage capital across generations, which fits naturally with the multi-year holding periods that mortality-linked assets require. The mismatch between asset duration and investor patience is one of the most reliable destroyers of return in alternative investing; family offices are typically free of it.

The second is the absence of quarterly mark-to-market pressure. Endowments and certain pensions report to boards and stakeholders on quarterly or annual cycles that incentivize smoother-looking mark-to-market valuations. Family offices generally face fewer such pressures and can tolerate the step-wise return pattern that life settlements and policy-backed loans produce. The result is a structural advantage: the same asset that produces uncomfortable quarterly reports for a pension may produce perfectly reasonable annualized returns for a multi-generation family balance sheet.

The third is willingness to engage with idiosyncratic, contract-heavy investments. The asset class rewards investors who are prepared to read the documents, understand the regulatory framework, and ask the structural questions. Family offices are often staffed and advised in ways that make this possible.

How to start due diligence

An allocator looking seriously at the category typically works through several lines of inquiry. None of these are unique to insurance-linked investing, but each has a particular flavor here.

• •Sourcing discipline: where does the manager get its policies, and what are the controls that ensure transactions originate through licensed channels with proper disclosures and consents?
• •Underwriting methodology: what is the manager's view of mortality distributions, how does it reconcile third-party life expectancy reports with its own modeling, and how disciplined is the bid process?
• •Portfolio construction: how is the book diversified across age, gender, medical profile, carrier, and policy type, and what concentration limits apply?
• •Valuation: who values the portfolio, on what cadence, and how independent is the valuation function from investment decisions?
• •Governance and audit: what are the fund administrator, custodian, valuation agent, and auditor arrangements, and how frequently are policies and records audited?
• •Risk management: how is longevity risk modeled, monitored, and stress-tested? How are premium projections built and updated as carriers change cost-of-insurance schedules?

The questions overlap with those an allocator would ask any private market manager. The novelty is in the specific answers and in the technical literacy required to evaluate them.

A note on language and framing

Throughout this article we have tried to avoid certain framings that we believe misrepresent the asset class. We have not described life settlements as a way to "outsmart" insurance carriers, because the carriers price their products to be held to the contract terms and the secondary market is a transfer of an already-issued policy from one holder to another. We have not described returns as coming from "arbitrage," because there is no riskless profit available — there is only compensated risk transfer. And we have not described the asset class as a way to "benefit when people die sooner," because the timing of the underlying mortality event is determined by factors entirely outside any investor's influence and the policyholder has already decided that the policy is no longer wanted.

These framings matter. Investors who hold the asset class for the right reasons tend to make better decisions about position sizing, stress testing, and time horizon. Investors who hold it for the wrong reasons tend to be disappointed when the actual return pattern fails to match the mistaken framing.

A short closing

Life-insurance-linked investing is not a category that fits every portfolio, and the diligence required to enter it intelligently is real. For family offices with long horizons, comfort with complexity, and patience for the cash flow patterns that mortality-linked assets produce, the category has a defensible place in the alternative sleeve.

Why manager selection dominates outcomes in this asset class

Most of what we have described as risks of the asset class — illiquidity, modeling uncertainty, the complexity of premium servicing, the need to maintain policies in force for years, the operational machinery of fund administration and independent valuation, the discipline of saying no to mispriced policies — are not, in our view, the asset class's failure modes in the abstract. They are operational realities that experienced managers handle as a matter of routine and that inexperienced managers stumble over. The clearest predictor of an investor's experience in this category is whether the manager has done the work before, has the institutional infrastructure to do it consistently, and has the discipline to walk away from acquisitions that do not meet underwriting standards.

This is the case for being unusually selective about manager choice in life-insurance-linked investing — more so than in many alternative categories. The dispersion in outcomes across managers tends to be wide. The features that drive that dispersion are not visible from quarterly statements but become visible in how the manager sources policies, how it makes bid decisions, how it handles premium servicing, how it values its portfolio, and how it manages its underlying service-provider relationships. Allocators who do the work to evaluate these features carefully tend to do well in the asset class; those who do not, do not.

About Sea Point Capital

Sea Point Capital was founded with a specific point of view about how this asset class should be approached. Our team brings over 40 years of combined experience in life settlements, fund management, and insurance-linked securities, with Michael and Avery having more than 20 years of working relationship before founding the firm. That continuity of partnership across decades — and across multiple cycles in the asset class — is something we take seriously as a foundation for the work.

Our approach has three distinguishing elements. We hold the full three-asset combination — life settlements, policy-backed loans, and payout annuities — rather than only life settlements, because we believe the combination produces a more durable portfolio than any single sleeve alone. We have built AI-enhanced underwriting tools that augment rather than replace the actuarial judgment at the core of policy pricing, applying that discipline equally to acquisitions and to collateral pools we underwrite as a lender. And we maintain the institutional service-provider infrastructure — independent fund administration, independent valuation, audit by a registered firm — that this asset class demands and that allocators are right to look for.

A fuller introduction to our strategy, our team, and our investment process is available at seapoint.capital. The next step, for an allocator who has read this far and wants to understand the category in more depth, is usually a conversation with our team to ask questions, discuss portfolio objectives, and understand structural terms.